A pproximately 7.3 million people die of ischemic heart disease globally every year, and almost 1 in every 6 deaths occurs in the United States because of cardiovascular disease. 1 Multiple modalities of therapies have been under investigation for improving cardiac function post-myocardial infarction (MI) and preventing onset of heart failure. For the last 2 decades, stem cell therapy has become an exciting potential for therapy for improved cardiac remodeling post-MI. Although initially thought to be directly the contribution of cells themselves, the majority of researchers now think that paracrine mechanisms are likely the benefit of cell therapy. This holds true for many cell types, including but not limited to mesenchymal, hematopoietic, and cardiac-derived cell types. February 17, 2017 that paracrine effects play a major role in the beneficial effects observed after CPC therapy. 3 Despite the data that suggest that CPCs do not form new myocytes, clinical trials involving CPCs 4 and other cardiac-derived cells, such as cardiosphere-derived cells (CDCs), [5] [6] [7] show modest benefits in the clinic. Despite the clinical advances, mechanisms for recovery are still under investigation.
Exosomes have gathered a growing interest recently when it was determined that they carry mRNAs and microRNAs that contribute toward intercellular signaling. 8 Since these important findings, few studies have been published documenting the important role of exosomal-driven myocardial healing post-MI, including a recent study from our group showing that rat CPCs make exosomes. When culturing these CPCs under hypoxic conditions, microRNA content was changed and exosomes improved post-MI repair. 9 Furthermore, CDC-derived exosomes also improve ventricular remodeling and exert antifibrotic, angiogenic, and antiapoptotic response on the myocardial healing. 10 Finally, recent studies suggest that exosomes derived from several different cell types improve myocardial repair, including mouse embryonic stem cells 11 and human CD34 + stem cells. 12 Adding to the importance of exosomes, a recent study demonstrated that blockade of exosome secretion decreased the benefits of CDC therapy, 13 establishing the involvement of paracrine secretion from stem cells in cardiac repair.
During embryogenesis, all the cells of a developing fetus, including stem cells, grow in a relative hypoxic environment, suggesting that hypoxia induces regenerative effects. 14 Moreover, we have recently shown that younger CPCs have more beneficial effects compared with older CPCs because their efficacy decreases by the time the child reaches 1 year of age. 15 Based on these observations, we hypothesized that exosomes derived from hypoxic and neonatal CPCs can improve ventricular remodeling post-MI. In this report, we tested the effect of donor age and hypoxia on exosomes derived from various pediatric age group CPCs (neonates, infant, and child) in ventricular remodeling post-MI. We then used computational modeling, incorporating studies using other human cell types to strengthen our model, to predict potential mediators.
Methods

Human Sample Acquisition and Isolation of c-KitPositive Human CPCs
This study was approved by the Institutional Review Board at Children's Healthcare of Atlanta and Emory University. Approximately 70 to 100 mg of right atrial appendage tissue was obtained from children with varied congenital heart diseases undergoing reconstructive heart surgeries. Human c-kit-positive CPCs were isolated and characterized as described previously. 15 In brief, right atrial appendages of the children undergoing cardiac surgeries for various reasons were isolated and transported using Krebs-Ringer solution containing 35 mmol/L NaCl, 4.75 mmol/L KCl, 1.2 mmol/L KH 2 PO 4 , 16 mmol/L Na 2 HPO 4 , 134 mmol/L sucrose, 25 mmol/L NaHCO 3 , 10 mmol/L glucose, 10 mmol/L HEPES, and 30 mmol/L 2,3-butanedionemonoxime, pH 7.4, with NaOH. The appendages were minced and were digested using collagenase type 2 from Worthington (300 U/mL). The digested tissue was filtered, and cells were pelleted by centrifuging at 1000g for 5 minutes. The cells were then mixed with beads coated with anti-c-kit antibody (Santa Cruz H300) followed by magnetic sorting and washes with media. Cells were grouped into 3 What Is Known?
• Stem cell therapy for myocardial infarction has provided mixed results, with beneficial paracrine signaling because of exosomes being a mechanistic explanation.
• Children have a population of cardiac progenitor cells that reside in the heart and are thought to be beneficial, though function varies greatly with age.
• How donor age and hypoxia affect exosome quality and reparative potential is unknown.
What New Information Does This Article Contribute?
• Pediatric cardiac progenitor cells secrete exosomes that differ greatly in their microRNA content.
• Exosomes from newborns are reparative and efficacy decreases with age; hypoxic preconditioning of cells restores exosomal function.
• Computational modeling can create predictive models based on microRNA content and can predict function of other cellular-derived exosomes, leading to identifying new functions of microRNAs.
There is growing evidence that the benefits of stem/progenitor cell therapy are due, at least in part, to the paracrine effects of stem/progenitor cells. Most cells package intracellular bioactive molecules in exosomes, which contain surface markers that can fuse with recipient cells. This process allows for direct intracellular delivery of cellular components, including microRNAs. We found that cardiac progenitor cells derived from children release exosomes that can repair the infarcted heart, although their efficacy decreases sharply with age. Subjecting cells to hypoxia restored reparative potential of the exosomes and changed their microRNA content. Based on computational modeling, we could hypothesize which microRNAs were contributing to specific outcomes and even extend our model to other cell-derived exosomes. By analyzing microRNA data from prior studies, we were able to not only predict the function of those exosomes, but also use the new data to generate hypotheses about unknown microRNA functions. Finally, we report an unbiased way to determine whether covarying microRNAs can influence specific functions and provide the groundwork for aggregation of data into larger computational models to better predict and characterize exosome functions.
Novelty and Significance
age groups for the studies as follows: neonate (0-1 months), infant (1-12 months), and child (2-5 years).
Media Components
CPCs were cultured in media that consisted of Hams F12 medium supplemented with 50 mL of fetal bovine serum, 5 mL of antibiotic and antimycotic, 5 mL of l-glutamine, and 200 μL of human fibroblast growth factor-2 (25 mg/mL). CPC quiescent as well as treatment media consisted of Hams F12 medium supplemented with 1% antibiotic (5 mL) and antimycotic, 1% l-glutamine (5 mL) neither fetal bovine serum nor bFGF were used. Cardiac endothelial cells were cultured in complete rat endothelial cell medium from Cell Biologic (Cat No. M1266) containing 0.5 mL of EGF (epidermal growth factor), 0.5 mL of VEGF (vascular endothelial growth factor), 5 mL of l-glutamine, 5 mL of antibiotic-antimycotic solution, and 10 mL of fetal bovine serum. Cardiac fibroblast media consisted for 50 mL of fetal bovine serum, 5 mL of l-glutamine, 5 mL of penicillin, and 5 mL of streptavidin in DMEM. All final media volumes were 500 mL.
Generation and Isolation of Exosomes
Pediatric human CPCs were quiesced in serum-free media for 12 hours followed by a media change and either normoxic or 1% oxygen conditions for another 12 hours. Conditioned media was collected and pooled from 3 separate individual patient cell lines per age range for 3 passages to reduce variability. The conditioned media was subjected to multiple ultracentrifugation steps using Optima XPN-100 Ultracentrifuge (Beckman Coulter), and exosomes were collected. In brief, the conditioned media was centrifuged at 7500 rpm for 5 minutes at 4°C to pellet the debris, followed by 2 washes in PBS at 24 000 rpm for 70 minutes at 4°C. The exosome pellet was isolated, and the protein content of the exosomes was analyzed by Micro BCA Protein Assay kit (Thermo Scientific Pierce 23235) according to the manufacturer's instructions. Transmission electron microscopy (JEOL JEM-1400) was used to determine the presence, as well as the size, of the exosomes.
Exosome Labeling With Acridine Orange and Uptake Study
Exosomes were labeled with acridine orange (AO) as described. 9 In brief, 500 μmol/L AO stock was prepared in autoclaved water and combined with 4 μg of exosomes (diluted in PBS) in a 1:24 ratio to yield 2 mL of sample with an AO concentration of 20 μmol/L. The sample was incubated at room temperature for 90 minutes. Subsequent dialysis in PBS was performed at 4°C with buffer changes at 2 and 4 hours before leaving the sample in buffer overnight. The labeled exosomes were covered and stored at −80°C. For the uptake study, rat adult cardiac myocytes, rat cardiac fibroblasts, and rat cardiac endothelial cells were incubated with 1 μg of labeled exosomes for 2 hours. Nuclei were stained with Hoescht, and live cell imaging was performed using an Olympus Fluoview FV-1000 confocal microscope (Olympus, Melville, NY). Fluoroscence was analyzed using Image J.
Animal Surgery
All animal experiments were performed with the approval of the Institutional Animal Care and Use Committee of Emory University. Athymic rats (Crl:NIH-Foxn1 rnu ; ≈250 g) were obtained from Charles River Laboratory. Rats were anesthetized with 2% of isoflurane (Isolurane, USP Piramal Healthcare), orally intubated, and ventilated. The left anterior descending coronary artery was ligated for 30 minutes followed by reperfusion. Exosomes (80 μg/kg suspended in 100 μL of PBS) were injected into the myocardium at 3 different sites of the border zones in a randomized and double-blinded manner. Twodimensional echocardiography was performed at day 3 and 28 post-MI (Acuson Sequoia 512 with a 14 MHz transducer). All functional evaluations were conducted and analyzed by investigators blinded to the animal's treatment group. After 28 days, the rats were euthanized and the hearts were excised for histological analysis. The hearts were fixed in formalin followed by paraffin embedding.
Picrosirius Staining
Collagen staining was done as described. 15 In brief, the paraffinembedded sections were dewaxed using histoclear (10 minutes×2). Multiple ethanol washes were performed in series followed by 1-hour incubation with picrosirius red solution (Sigma). The sections were washed with acetic acid for 45 minutes followed by 100% ethanol for 1 minute and finally mounted with resinous medium (Cytoseal). Images were taken using a slide scanner-Hamamatsu Nanozoomer 2.0HT. Percent fibrosis of the left ventricle (LV) was quantified using Aperio Imagescope v12.1.0.5029 software. The LV wall was traced, excluding the pericardium, and a line was drawn bisecting the muscular septum equally to calculate the LV region. The percent fibrosis was quantified using strong positive signal divided by total signal.
Immunostaining
Rats were euthanized at day 28 post-treatment. Hearts were harvested and fixed in formalin followed by paraffin embedding. Capillary and cell membrane staining was performed as described. In brief, paraffin wax was removed from the 7-μm tissue sections using histoclear (10 minutes×2) followed by various ethanol washes. Antigen retrieval was performed using sodium citrate (10 mmol/L) followed by blocking with 2% BSA. For capillary staining, tissue sections were incubated overnight with Isolectin GS-IB4, Alexafluor 647 conjugate from Life Technologies (1:25 dilution) at 4°C. Cell membrane staining was performed using Rhodamine-conjugated wheat germ agglutinin from Vector Laboratories (RL1022, 1:250 dilution).
Hypertrophy Analysis
Two-dimensional echocardiography was used to quantify the posterior wall thickness. The m-mode quantification of posterior wall thickness was measured at mid-papillary level for various groups. Histological assessment of hypertrophy was performed by labeling myocyte borders with wheat germ agglutinin. The cross section of at least 15 myocytes per field in the peri-infarct zone with centrally placed nucleus was quantified and averaged. A sample histogram from one sham and one ischemia-reperfusion (IR) animal is shown in Figure I in the online-only Data Supplement.
Infarct Sizing
Myocardial infarct size was evaluated using 2,3,5-triphenyltetrazolium chloride staining and Evans Blue dye, in which the percent area of infarction was calculated as the infarcted area (2,3,5-triphenyltetrazolium chloride stained) divided by the ischemic area at risk. Cytokine analysis and infarct size were performed at 24 hours after reperfusion.
MicroRNA Array Analysis
Exosomes were isolated from 3 individual human CPC cell lines belonging to children with 3 different age groups and then pooled to form neonate, infant, and child exosomes. RNA was extracted, and whole gene and microRNA array was performed using Affymetrix microRNA arrays by the Emory Integrated Genomics Core. Principal component (PC) and partial least squares regression (PLSR) analysis were performed using the SIMCA-P software (UMetrics) that solves the PLSR problem with the nonlinear partial least squares algorithm.
Statistical Analysis
Statistics were calculated with GraphPad Prism software as described in the legends. Unpaired t test was used where appropriate. One-way ANOVA was used with Tukey's posttest when multiple groups were compared.
Results
Exosomal Uptake in Cardiac Cells
Isolated CPC exosomes were generated as described and were visualized using transmission electron microscopy ( Figure 1A ). The size of the exosomes did not vary in between the hypoxic and normoxic groups and was determined to be 120±12 nm. Exosomes were labeled with AO, and the various February 17, 2017 cardiac cell types (rat cardiac myocytes, rat fibroblast, and rat endothelial cells) were incubated for 2 hours to determine uptake. Our results demonstrate that the exosomes are taken up by target cells at varying levels. All 3 major cardiac cell types (fibroblast, endothelial, and cardiomyocytes) internalized labeled exosomes, though there were cell-specific differences. Cardiac myocytes internalized exosomes to a minimal extent ( Figure 1B ). More uptake was seen in endothelial cells ( Figure 1C ), and maximal uptake was seen in fibroblasts ( Figure 1D ). Data were quantified in Figure II in the onlineonly Data Supplement. We further tested if the minimal uptake of exosomes in cardiac myocytes resulted in any phenotypic changes by performing sarcomere shortening and calcium transient measurements; however, we found no significant changes in the cardiac myocytes treated with either normoxic and hypoxic exosomes compared with controls ( Figure III in the online-only Data Supplement).
Hypoxic and Neonate CPCs-Derived Exosomes Improve Cardiac Function
Twenty microgram of CPC exosomes were delivered to athymic rats after 30 minutes of IR injury. These rats were followed for 28 days, and ejection fraction (EF) was recorded at day 3 and day 28 post-IR. At day 3 post-IR, our results demonstrate a statistically significant improved EF in athymic rats treated with either neonatal normoxia or neonatal hypoxia exosomes compared with the controls. CPC exosomes isolated from other older groups, including infant and child, from either normoxic and hypoxic cultures did not significantly improve the EF compared with those from the IR controls (Figure 2A) . Interestingly, at day 28 post-MI, neonatal normoxia and hypoxia groups retained their improved EFs; however, infant and child CPC exosomes from hypoxic, but not from normoxic, cultures resulted in statistically significant improvement of EF compared with CPC exosomes from the control ( Figure 2B ).
Hypoxic CPCs-Derived Exosomes Improved Fibrosis and Angiogenesis
To further decipher the mechanisms responsible for improved EF as described earlier, we examined fibrosis and angiogenesis in the infarcted region. Picrosirius red collagen staining was performed to determine the collagen content at day 28 post-IR. The percent collagen content was analyzed at the level of papillary muscles. Our results demonstrate that the athymic rats treated with hypoxic exosomes from various age groups showed significantly decreased fibrosis compared with their normoxic counterparts, as well as the IR control animals. Interestingly, despite improved cardiac function, the neonatal normoxic CPC exosomes treatment had no improvement in fibrosis ( Figure 3) .
We further analyzed the angiogenesis within the infarcted region of the heart. Isolectin staining was performed to label the capillaries, and counting was performed at 3 different places within the infarcted region. Our results show that angiogenesis was significantly improved among the hypoxic exosome groups compared with their normoxic counterparts and IR control animals (Figure 4) , suggesting that treatment of hypoxic CPC exosomes have a beneficial effect in ventricular remodeling. Consistent with fibrosis, neonatal normoxic CPC exosomes had no significant effect on angiogenesis.
CPCs-Derived Exosomes Improve Hypertrophy
To determine the effect of CPC exosomes on hypertrophy of the cardiac myocytes, histological and echocardiographic measurements were performed. We analyzed peri-infarct hypertrophy histologically by measuring the cross sections of cardiac myocytes at the level of a visible nucleus (stained with DAPI) at 3 different peri-infarct locations within the myocardium of all the groups. The cardiac myocyte cell membranes were labeled with wheat germ agglutinin ( Figure 5A ). Our results demonstrate that irrespective of age and oxygen content of the culture environment, CPC-derived exosomes decrease peri-infarct hypertrophy significantly ( Figure 5B compared with IR controls. We further analyzed the remote hypertrophy by measuring LV posterior wall diameter at day 28 post-IR by 2-dimensional echo. Interestingly, our results demonstrate that relatively younger groups, including neonatal and infant hypoxic CPC exosomes, had statistically improved LV posterior wall diameter compared with IR controls. Furthermore, hypoxic CPC exosome treatment significantly improved LV posterior wall diameter compared with normoxic CPC exosomes; however, no significant differences were observed in between the other hypoxic and normoxic groups ( Figure 5C ).
Computational Modeling of MicroRNAs
To predict the mechanisms responsible for these observed outcomes, we used an approach of PC analysis and PLSR. We have used this approach in the past to establish relationships between covariant microRNAs within CPCs and exosomes and their regenerative effects. For this study, we performed whole microRNA array from the exosomes derived from 3 individual patients in each group to establish a relationship between donor CPC age and environment (cues), microRNAs (signals), and responses of EF at day 3 and 28, angiogenesis, and fibrosis using PLSR. PC scores plot illustrates tight clustering in PC space by age, as well as hypoxia ( Figure 6A ). Variable importance of projection calculations determined each microRNA signal's contribution to an outcome. Of the top 100 microRNAs, we used miRTarBase to isolate microRNAs with known targets (by at least 3 assays). Our analysis returned 32 microRNAs, which were then plotted in PC space with outcomes ( Figure 6B ). 
Validation of Our Computational Model
Because several other studies have shown a benefit of exosomes and performed sequencing, we created a predictive model to determine whether we could use data from other studies to test and enhance our model. We chose data from a study on CD34 + cells because they showed a similar phenotype (angiogenesis) and were human derived, and complete microRNA sequencing was available. 12 Using this combined data, we made predictive models shown in Figure 7A using our top 30 microRNAs. This model had high predictability for angiogenesis and slightly less so for other functions because that article did not measure cardiac function or fibrosis. As the graph in Figure 7B shows, we were able to predict (white bars) data from the paper (black) with a high degree of fidelity. We then replotted all array data in PC space ( Figure 7C) and showed tight clustering of CD34 + cell-derived exosomes, with exosomes derived from newborns. Finally, in Figure 7D , we created a new PLSR model using all microRNA data from both studies to predict common microRNAs from both studies that contribute to the reparative phenotype. Because our predictive model only took into account the top microRNAs, we made another predictive model using the complete data set of microRNAs, and so it may be more generalizable ( Figure III in the online-only Data Supplement).
Neonate CPCs-Derived Exosomes Have Acute Cardioprotective Effects
Because our results showed that neonate CPCs-derived exosomes improved EF at day 3 and 28 post-IR, we evaluated their acute effect on infarct size and potential mechanisms Figure 5 . Hypertrophy analysis. Hypertrophy was analyzed in the peri-infarct region by immunostaining and left ventricular posterior wall diameter (LVPWd) by 2-dimensional (2D) echo. A-B, Immunostaining for wheat germ agglutinin (red) and nuclei (DAPI) was performed for peri-infarct hypertrophy. Cross-sectional area of cardiac myocytes at the level of the nuclei in plane in the peri-infarct region was determined at 3 different areas of each animal. Ai -Aiii, Representative images as labeled. B, Grouped data represents mean±SEM of cross section area of a myocyte (μm 2 ). Exosomes from all groups showed significantly decreased hypertrophy compared with control (n=4-5). *P<0.05; ANOVA followed by Tukey-Kramer posttest. C, M-mode images of 2D echo were quantified for determining LVPWd. Grouped data represent mean±SEM of LVPWd. Exosomes from neonatal hypoxia showed significant decreased hypertrophy compared with controls and neonatal normoxia groups. Exosomes from infant hypoxia showed significant decreased hypertrophy compared with controls. *P<0.05; Unpaired t test. February 17, 2017 by performing 2,3,5-triphenyltetrazolium chloride staining and by evaluating expression of various cytokines in the tissue using Luminex expression analysis, respectively. Our results demonstrate that although there was a 25% reduction in infarct size of rats treated with normoxic-derived neonatal CPCs exosomes, no statistical difference between the control (IR+saline only) and neonatal normoxic CPC exosome group was observed. In contrast, hypoxia-derived neonate CPC exosomes significantly (P<0.05) reduced the infarct size (Figure 8 ), suggesting an acute beneficial effect in addition to the improved angiogenesis and decreased fibrosis. We further analyzed potential mechanisms of these observed effects by quantifying the cytokine content using Luminex analysis. Our results show that interleukin-6 was significantly reduced in rats treated with hypoxia-derived neonate exosomes and to a smaller degree interleukin-1α (not significantly decreased). In addition, interleukin-18 levels were significantly upregulated in the rats treated with neonate CPCs-derived exosomes (and to a lesser degree interleukin-10; Figure V in the online-only Data Supplement).
Discussion
Since their discovery in 2003, CPC therapy has rapidly advanced to clinical trials without complete understanding of mechanisms involved. Although once thought to be direct cardiac differentiation of these cells, it is now widely accepted that the beneficial effects of CPCs are driven via paracrine mechanisms, including secretion of cytokines and vesicles into the extracellular space. Recently, exosomes have moved to the forefront of potential paracrine mediators because of their ability to carry microRNAs and influence local gene expression. Multiple groups, including our laboratory, have published that progenitor cells produce exosomes carrying microRNAs that can improve ventricular remodeling. In this study, we found that human pediatric CPCs generate exosomes with the size of 120±12 nm, similar to what is reported in that literature. 16, 17 A recent study showed that human CPCs-derived extracellular vesicles reproduced the similar beneficial effects compared with their parent cell in chronic heart failure model. 18 Although interesting, this study looked at embryonic stem cell-derived CPCs and not isolated from tissue. Additionally, exosomes were not separated from the total extracellular vesicle content. Nonetheless, the current study builds on this one, as well as our prior study of rat CPCderived exosomes. There are reports of exosomes from many cell types improving cardiovascular repair, including CD34 + cells, 12, 19, 20 CDCs, 10,13 embryonic stem cells, 11, 21 and mesenchymal stem cells. 22, 23 Although the potential mechanisms may differ slightly, all of these exosomes show improvements in similar outcomes, including fibrosis, angiogenesis, and cardiac function, suggesting some potential common mechanisms. What these data do show, which is rather interesting, is that many of the benefits of cell therapy can be recapitulated without the cells themselves. This is important for sources such as embryonic stem cells, which have tumorigenicity concerns that showed no tumorigenicity of exosomes, 11 and may alleviate the concerns of many other cells. Moreover, exosomes, as cell-free sources, have the potential to be allogeneic therapy. This could mean that a single optimal source could be obtained and standardized, another important limitation of cell therapy.
Our study also demonstrates that all 3 major cardiac cell types (fibroblast, endothelial, and cardiomyocytes) internalize human pediatric CPCs as shown by confocal imaging of AO-labeled exosomes. There were cell-specific differences, with fibroblasts taking up the most exosomes, followed by endothelial cells; however, cardiomyocytes minimally internalized exosomes. Although studies have suggested that myocytes produce exosomes, 24, 25 this is the first report of cardiac myocytes internalizing exosomes. Despite this, many studies show improvements in cardiac function without any particular effect on myocytes themselves, including some from our laboratory. Furthermore, a recent study by Tseliou et al 10 showed that fibroblast cells primed with CDC-derived exosomes exhibited antifibrotic, antiapoptotic, and angiogenic effects, suggesting that uptake of exosomes by fibroblast cells may be enough to drive the regenerative/ reparative process. Regardless, this minimal uptake of exosomes by cardiomyocytes produced little functional effects on the myocytes themselves.
Our study is an attempt to understand the role hypoxia and age of the CPCs play in modulating the effect of exosomes generated from these cell types. We observe that neonatal exosomes irrespective of the environment have improved ventricular function at day 3 and day 28 post-IR. This earlier preservation of cardiac function at day 3, along with our finding that exosomes from neonatal cells under normoxia improved function independent of fibrosis and angiogenesis, suggest an interplay of a single or multiple acute mechanisms. Given our findings that exosomes are not taken up by cardiomyocytes, we speculate that actions on local fibroblasts, or perhaps even infiltrating inflammatory cells, could improve myocyte survival. Moreover, we do not rule out the possibility of exosome-reprogrammed fibroblasts and endothelial cells modulating the cardiomyocyte function via secretion of potent endogenous exosomes taken up by myocytes. This remains an interesting area for future studies.
We also analyzed cardiac myocyte hypertrophy among these groups in the peri-infarct zone histologically. Our data demonstrates that all the groups had decreased peri-infarct hypertrophy compared with the controls, suggesting that even the exosomes generated in the normoxic conditions might have some beneficial role, although not physiologically relevant. Interestingly, on measuring the LV posterior wall diameter, we found that hypoxic exosomes from neonate CPCs had the significantly decreased hypertrophy compared with their normoxic counterparts and control animals. Furthermore, hypoxic exosomes from infant CPCs also had improved hypertrophy compared with controls but not with their normoxic counterparts. These results suggest that although the phenotypes of child and infant exosomes are similar, small intricacies and disparities still exist.
Recently, our laboratory showed that the efficacy of ratderived CPC exosomes increases after subjecting cells to hypoxia. Moreover, the microRNA content in the hypoxic exosomes also changed with hypoxia, suggesting that possible compensatory pathways exist in the CPCs to alter secretion based on microenvironmental cues. 9 Although the mechanism for this is unclear, it could be possible that pathways involving proteins such as hypoxia inducible factor-1 play a role. Our results also demonstrate that hypoxia reverses the phenotype of infant and child CPC-derived exosomes because we observed improved remodeling via increased angiogenesis and decreased fibrosis, suggesting another therapeutic approach in increasing the quality of these exosomes. Because our recent study showed donor age-dependent effect of cells in response to right ventricular overload repair, 15 it is possible that hypoxia could alter the reparative phenotype of these cells as well.
To predict the molecular mechanisms responsible for the observed findings, we took a computational biology approach. MicroRNA analysis revealed an age-and hypoxiadependent clustering of the different human CPCs-derived exosomes. PC analysis showed few differences between microRNAs from neonate cells in response to hypoxia, which is interesting considering outcomes were not considered in this initial analysis. At baseline (normoxia), exosome microRNA clusters uniquely by age, suggesting specific age-related differences. Hypoxia brings infant and children-derived exosomes into a different quadrant, suggesting potential covarying changes occurring that are hypoxia specific. PLSR analysis gave quantitative outputs to how likely each microRNA was involved in our response. Certain microRNAs identified by our analysis have been shown to regulate important functions like fibrosis (miR-27a and miR-29c 26, 27 ), cardiac hypertrophy (miR-29c, 28 miR-96, 29, 30 miR-182, 31, 32 and miR-185 33 ), angiogenesis (miR-27a 34 ), and apoptotsis (miR-138 35, 36 and miR-25 37 ). Although our model is predictive of microRNA-based mechanism, these targets still need to be validated in the future studies. Our prior study showed that inhibition of the recipient cell RISC (RNA-induced silencing complex) abrogated the effects of the exosomes, suggesting microRNA-mediated mechanisms, but we do not rule out the effects of any proteins or other species found in exosomes. The use of computational biology to help differentiate these signals is a powerful tool that could help bring thousands of microRNAs to a reasonable level that can be used to predict future values. We ran the miR arrays on the exosomes derived from 3 patients from each group (3 individual patients were run, and data were averaged for statistics). Although the number of patient samples is lower than desired, our prior study found tight clustering of signals within cells from patients within similar age groups. Additionally, the number of patients sampled is similar to that in prior studies to model kinase pathways. Although the ages were similar in the groups, the diagnoses and genders of the patients were different. We excluded any patient with known genetic mutations; however, many of these patients may have undiagnosed underlying genetic problems, and our study did not account for that. To counter all of these issues, more patient samples need to be added to perform multivariate analysis to account for patient-to-patient variability.
Although a model of human pediatric CPCs is of great interest, expanding this model to include other reparative exosomes from other cell types would be extremely valuable. Identifying both unique and common signals that contribute to exosome function could help predict the efficacy of other exosome sources, as well as generate synthetic exosomes with selected signals. We have generated a new predictive model with our exosome data and used published array data from CD34 + progenitor cell exosomes to refine our model and successfully predict published angiogenic data. This combined model showed that CD34 + cell-derived exosomes are predicted to behave similarly to CPC exosomes and also provide a clearer map of potential signals that are shared between the 2 different cell types. Moreover, we examined the potential involved in miRs identified with our model by Ingenuity Pathway Analysis. Potential pathways targeted by these miRs scoring the strongest included regulation of cell cycle and cell survival, giving potential insights into future studies with combined exosome treatment ( Figure VI in the online-only Data Supplement). We also tested several of the predicted miRs that had no published function in vitro to validate our model. As the data in Figure VII in the online-only Data Supplement show, all of the miRs predicted by our models to alter angiogenesis increased tube formation in transfected HUVECs (human umblical vein endothelial cells; miRs196a, -335, -518f, -532, and -548b). With many exosome papers now being published, the possibility exists to make our model even more powerful by incorporating data from other cell types and determining novel roles for unstudied miRs.
Interestingly, we also show that exosomes derived from neonates reduce infarct size, though only exosomes from cells subjected to hypoxia showed significant decreases. As normoxic exosomes improved function independent of fibrosis and angiogenesis, this reduction seen acutely could carry over to the chronic phase. In addition, we also saw changes in secreted factors. As our data show, exosomes were not taken up by cardiomyocytes, understanding how local exosome uptake affects the postinfarct microenvironment is an interesting area for further examination. Our study adds on to the growing literature of exosomal reparative potential for cardiac disease and reports a novel finding of donor age-dependent effects of CPC-derived exosomes within the pediatric population. Because numerous studies show the benefit of pediatric cells to adult cells, finding the optimal conditions within the pediatric population could help inform future therapeutic strategies. We also found that hypoxia could restore the reparative effect of exosomes in cells that have diminished ability to produce beneficial exosomes. Finally, we used computational modeling to examine covarying signals between the groups, simplify the large amount of data generated, and predict the role of individual microRNAs both within our study and from other studies as well. Although these are just predicted mechanisms, it may help generate novel predictions for future studies.
